RPID Logo

Rapid Micro Biosystems, Inc. (RPID) 

NASDAQ
Market Cap
$48.06M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
220 of 776
Rank in Industry
31 of 100

Largest Insider Buys in Sector

RPID Stock Price History Chart

RPID Stock Performance

About Rapid Micro Biosystems, Inc.

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) …

Insider Activity of Rapid Micro Biosystems, Inc.

Over the last 12 months, insiders at Rapid Micro Biosystems, Inc. have bought $141,663 and sold $0 worth of Rapid Micro Biosystems, Inc. stock.

On average, over the past 5 years, insiders at Rapid Micro Biosystems, Inc. have bought $1.41M and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Kollender Richard S (director) — $50,128. Malloy Kirk (director) — $45,335. Spignesi Robert G. Jr. (PRESIDENT AND CEO) — $38,400.

The last purchase of 50,000 shares for transaction amount of $45,335 was made by Malloy Kirk (director) on 2024‑08‑08.

List of Insider Buy and Sell Transactions, Rapid Micro Biosystems, Inc.

2024-08-08Purchasedirector
50,000
0.123%
$0.91$45,335+1.59%
2024-08-07PurchaseCHIEF FINANCIAL OFFICER
10,000
0.0243%
$0.78$7,800+14.99%
2024-08-06PurchasePRESIDENT AND CEO
50,000
0.1147%
$0.77$38,400+9.80%
2024-08-06Purchasedirector
65,000
0.1497%
$0.77$50,128+9.80%
2023-09-06PurchaseCHIEF FINANCIAL OFFICER
10,000
0.024%
$0.99$9,894-1.44%
2023-08-15PurchasePRESIDENT AND CEO
20,000
0.046%
$0.97$19,488-3.50%
2023-08-08PurchasePRESIDENT AND CEO
34,000
0.0817%
$0.92$31,447+5.98%
2023-05-17PurchasePRESIDENT AND CEO
20,000
0.0462%
$0.91$18,204+6.63%
2022-06-02Purchase
20,602
0.0446%
$4.66$96,100-62.92%
2022-05-27Purchase
19,414
0.0406%
$4.76$92,407-58.50%
2022-05-25Purchase
12,396
0.0323%
$4.90$60,774-49.44%
2022-05-17Purchase
11,125
0.0243%
$3.94$43,861-43.29%
2022-05-16PurchasePresident and CEO
10,000
0.0234%
$3.79$37,950-35.86%
2022-03-10Purchase
10,000
0.0262%
$6.95$69,500-46.34%
2021-07-19Purchase10 percent owner
100,000
0.2804%
$20.00$2M-59.26%
2021-07-19Purchase10 percent owner
150,000
0.4205%
$20.00$3M-59.26%

Insider Historical Profitability

<0.0001%
Spignesi Robert G. Jr.PRESIDENT AND CEO
540012
1.2584%
$1.1250<0.0001%
WIRTJES SEAN MCHIEF FINANCIAL OFFICER
348157
0.8113%
$1.1220
Kollender Richard Sdirector
96718
0.2254%
$1.1210
Malloy Kirkdirector
64300
0.1498%
$1.1210
Bain Capital Life Sciences Investors, LLC10 percent owner
8434560
19.6545%
$1.1210<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Bain Capital Life Sciences Investors Llc$8.18M19.688.43M0%+$00.66
Kennedy Lewis Management Lp$4.79M11.534.94M0%+$013.34
Glenview Capital Management$1.28M3.081.32M0%+$00.03
Abg Wtt Global Life Science Capital Partners Gp Ltd$768,339.002.421.04M0%+$01.85
BlackRock$989,136.002.381.02M-0.17%-$1,677.13<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.